Attune TruMatch (TM) Patient-Specific Instrumentation: Patients to receive total knee replacement with TruMatch Patient-Specific Instrumentation
Study summary
The purpose of our study is to determine, using a prospective, randomized-controlled trial, the economic viability and clinical outcomes associated with patient-specific instrumentation (PSI) for total knee arthroplasty in an obese patient population.
Eligibility
Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* patients with body mass index (BMI; kg/m2) greater than 30 and less than or equal to 50
* Symptomatic knee osteoarthritis deemed most appropriately treated with total knee arthroplasty
* Patient greater than 19 and less than or equal to 70 years of age
* English-speaking
Exclusion Criteria:
* History of prior open knee surgery, infection, or previous knee trauma
* Simultaneous bilateral knee arthroplasty
* Underlying dementia, cognitive delay, any disorder, or geographic distance that would preclude the completion of the clinical questionnaires
* Inflammatory arthropathy
* Chronic pain syndrome
* Fibromyalgia
Primary outcome measure(s)
Assessment of Possible Change in Radiographic Alignment — Pre-operatively, 6 weeks post-operatively, 1 year post-operatively Mechanical axis, sagittal alignment and tibial slope are to be assessed.
Trial sites (1)
Facility
City
Region
Status
London Health Sciences Centre, University Hospital
London
Ontario
More London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.